[Experience with Cefobid in severe infections complicating immunodeficiency diseases].
As a 3rd generation cephalosporin Cefobid monotherapy was applied during 1985-1986 with 16 hematological patients in immunodeficient, immunosuppressive states where the available aimed and combined antibiotic therapy failed to be effective for the treatment of bacterial infections of grave course and septic character. 4 g/day was the average I.V. dose of Cefobid, higher doses were applied only in especially grave septic states. The hematological patients tolerated well the Cefobid in monotherapy. Recovery form the septic state and excellent clinical effect was found with 9 patients, good effect with 4 and satisfactory effect with 1 patient. In 1 case the therapy had to be stopped owing to drug hypersensitivity. Cefobid is regarded as an antibiotic drug that is effective if used in monotherapy for treating grave, septic infections of hematological patients in immunodeficient--immunosuppressive--myelodepressive states having received earlier antineoplasmic polychemotherapy.
István
L
L
Bodnár
M
M
Marton
E
E
Lakatos
F
F
Végh
G
G
D000368:Aged; D000380:Agranulocytosis / Q000139:chemically induced / Q000276:immunology; D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D002415:Cats; D002438:Cefoperazone / Q000627:therapeutic use*; D006402:Hematologic Diseases / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000139:chemically induced; D007166:Immunosuppressive Agents / Q000009:adverse effects; D007938:Leukemia / Q000188:drug therapy* / Q000276:immunology; D008875:Middle Aged; D009894:Opportunistic Infections / Q000188:drug therapy / Q000209:etiology / Q000276:immunology*
D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D002438:Cefoperazone
Cefobiddal szerzett tapasztalatok immundeficiens haematologiai betegek súlyos fertözéseiben.